My Cart

CD73

CD73 Overview

English Name5'-nucleotidaseApproved Drugs0
Drugs in Clinical Trials32Target Synonym5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
Highest Development StagePhase 3 Clinical
English Name5'-nucleotidase
Target Synonym5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
Approved Drugs0
Drugs in Clinical Trials32
Highest Development StagePhase 3 Clinical

CD73 Background

5'-nucleotidase (5'-NT), also known as ecto-5'-nucleotidase or CD73 (cluster of differentiation 73), is an enzyme that is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. Ecto-5-prime-nucleotidase (5-prime-ribonucleotide phosphohydrolase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred substrate being AMP. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from ecto-NT5 by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. Rare allelic variants are associated with a syndrome of adult-onset calcification of joints and arteries (CALJA) affecting the iliac, femoral, and tibial arteries reducing circulation in the legs and the joints of the hands and feet causing pain.

CD73 Synonyms

CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UliledlimabTJ-4309; TJ-004309; TJD-5Phase 3 ClinicalI-Mab Biopharma Co LtdOvarian Neoplasms; Head and Neck Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Neoplasm Metastasis
Details
QuemliclustatAB-680Phase 3 ClinicalArcus Biosciences IncBiliary Tract Neoplasms; Pancreatic Neoplasms; Hormone-Resistant Prostate Neoplasms; Prostatic Neoplasms, Castration-Resistant; Cholangiocarcinoma; Prostatic Neoplasms; Colorectal Neoplasms; Bile Duct Neoplasms; Carcinoma, Pancreatic Ductal; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung
Details
OleclumabMEDI-9447Phase 3 ClinicalMedimmune LlcProstatic Neoplasms, Castration-Resistant; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Carcinoma, Pancreatic Ductal; Peritoneal Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Osteosarcoma; Urinary Bladder Neoplasms; Solid tumours; Liposarcoma; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Hemangiosarcoma; Ovarian Neoplasms
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncSolid tumours; Liver Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
BMS-986179BMS-986179Phase 2 ClinicalBristol-Myers Squibb CompanySolid tumours
Details
MupadolimabCPX-006; COR-004 (Corvus Pharmaceuticals); CPI-006Phase 2 ClinicalCorvus Pharmaceuticals IncPapillomavirus Infections; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Lymphoma, Non-Hodgkin; Endometrial Neoplasms; Colorectal Neoplasms; Sarcoma; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Head and Neck Neoplasms; Solid tumours
Details
DresbuxelimabAK-119Phase 2 ClinicalSolid tumours; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
S-095024S-095024; S095024Phase 2 ClinicalInstitut De Recherches Internationales Servier, Servier Bio-Innovation LLC, Regeneron Pharmaceuticals IncCarcinoma, Non-Small-Cell Lung
Details
HB-0045HB-0045; HB0045Phase 2 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, HuaBo Biopharm Co LtdSolid tumours
Details
JAB-BX102JAB-BX102Phase 2 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours
Details
PT-199PT-199Phase 2 ClinicalPhanes Therapeutics IncSolid tumours; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung
Details
LY-3475070LY-3475070Phase 1 ClinicalEli Lilly And CompanyNeoplasms
Details
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
Details
UprevstobartINCA-00186Phase 1 ClinicalIncyte Corp LtdSolid tumours; Squamous Cell Carcinoma of Head and Neck; Gastrointestinal Neoplasms
Details
AK-137AK137; AK-137Phase 1 ClinicalZhongshan Akeso Biopharma Co LtdNeoplasms
Details
68GA-DOTA-dPNE68GA-DOTA-dPNEPhase 1 ClinicalPeking Union Medical College HospitalBreast Neoplasms
Details
LNF-2008LNF-2008; LNF2008Phase 1 ClinicalShandong New Time Pharmaceutical Co LtdSolid tumours
Details
HB-0046HB0046; HB-0046Phase 1 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co LtdSolid tumours
Details
HB-0052HB-0052; HB0052Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdSolid tumours
Details
SYS-6011SYS6011; SYS-6011Phase 1 ClinicalJushi Biopharmaceutical Co LtdSolid tumours
Details
BPI-472372BPI-472372Phase 1 ClinicalBetta Pharmaceuticals Co LtdSolid tumours
Details
BB-1709BB-1709Phase 1 ClinicalBliss Biopharmaceutical (Hangzhou) Co LtdSolid tumours
Details
PM-1015PM1015; PM-1015Phase 1 ClinicalSolid tumours
Details
AK-131AK-131Phase 1 ClinicalZhongshan Akeso Biopharma Co LtdSolid tumours; Neoplasms
Details
IBI-325IBI-325Phase 1 ClinicalInnovent Biologics(Suzhou) Co LtdSolid tumours
Details
BR-101BR101; BR-101Phase 1 ClinicalBioRay Pharmaceutical Co LtdSolid tumours
Details
CB-708ATG-037; ATN-037; CB-708; CB708Phase 1 ClinicalCalithera Biosciences IncSolid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma
Details
HLX-23HLX-23Phase 1 ClinicalShanghai Henlius Biologics Co LtdSolid tumours; Lymphoma
Details
ORIC533ORIC-533Phase 1 ClinicalOric Pharmaceuticals IncMultiple Myeloma; Neoplasm Metastasis
Details
IPH-5301IPH-5301Phase 1 ClinicalInnate PharmaOvarian Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Neoplasms; Breast Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Metastatic breast cancer; Neoplasm Metastasis
Details
HBM-1007HBM1007; R 1007; HBM 1007; HBM-1007Phase 1 ClinicalHarbour BiomedSolid tumours; Neoplasms
Details
ABSK-051ABSK051Phase 1 ClinicalABbisko Therapeutics Co LtdSolid tumours; Neoplasms
Details

Product Reviews

  • H***g2021-11-29
    0People Like
    It was used in research of investgational new drugs. Specifically, I have used this product in my Epitope binning experiments (using Octet) and I am truely satisfied with the results. With this experiment and your product, we have found a approximate epitope binding site. Thanks for your highly qualified product._x000D_
  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland